Ceftazidime-avibactam/aztreonam combination synergy against carbapenem-resistant Gram-negative isolates: In vitro study
Background: The ceftazidime-avibactam combination is able to inhibit ESBLs, AmpCs and Class A carbapenemases and has been recommended for the treatment of complicated UTIs and ventilator-associated bacterial pneumonia. Aims: The present study was undertaken to evaluate the in vitro activity of cefta...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Serier: | Current Medicine Research and Practice |
| Fag: | |
| Online adgang: | http://www.cmrpjournal.org/article.asp?issn=2352-0817;year=2024;volume=14;issue=1;spage=16;epage=21;aulast=Rajan |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|